|
1
|
Burns WR and Zeiger MA: Differentiated
thyroid cancer. Semin Oncol. 37:557–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pellegriti G, Frasca F, Regalbuto C,
Squatrito S and Vigneri R: Worldwide increasing incidence of
thyroid cancer: Update on epidemiology and risk factors. J Cancer
Epidemiol. 2013:9652122013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morris LG, Tuttle RM and Davies L:
Changing trends in the incidence of thyroid cancer in the United
States. JAMA Otolaryngol Head Neck Surg. 142:709–711. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leboulleux S, Rubino C, Baudin E, Caillou
B, Hartl DM, Bidart JM, Travagli JP and Schlumberger M: Prognostic
factors for persistent or recurrent disease of papillary thyroid
carcinoma with neck lymph node metastases and/or tumor extension
beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol
Metab. 90:5723–5729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parangi S and Suh H: The role of genetic
markers in the evaluation and management of thyroid nodules. Surg
Clin North Am. 94:515–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xing M: Genetic alterations in the
phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.
Thyroid. 20:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xing M: BRAF mutation in thyroid cancer.
Endocr Relat Cancer. 12:245–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Elisei R, Viola D, Torregrossa L, Giannini
R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, et
al: The BRAF(V600E) mutation is an independent, poor prognostic
factor for the outcome of patients with low-risk intrathyroid
papillary thyroid carcinoma: Single-institution results from a
large cohort study. J Clin Endocrinol Metab. 97:4390–4398. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tavares C, Melo M, Cameselle-Teijeiro JM,
Soares P and Sobrinho-Simões M: ENDOCRINE TUMOURS: Genetic
predictors of thyroid cancer outcome. Eur J Endocrinol.
174:R117–R126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gustafson S, Zbuk KM, Scacheri C and Eng
C: Cowden syndrome. Semin Oncol. 34:428–434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morita N, Ikeda Y and Takami H: Clinical
significance of p53 protein expression in papillary thyroid
carcinoma. World J Surg. 32:2617–2622. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu X, Bishop J, Shan Y, Pai S, Liu D,
Murugan AK, Sun H, El-Naggar AK and Xing M: Highly prevalent TERT
promoter mutations in aggressive thyroid cancers. Endocr Relat
Cancer. 20:603–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Strausberg RL, Feingold EA, Grouse LH,
Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler
GD, Altschul SF, et al: Generation and initial analysis of more
than 15,000 full-length human and mouse cDNA sequences. Proc Natl
Acad Sci USA. 99:16899–16903. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lian PW, Fu YL, Li A, Dai BZ, Ding ZW, Li
L and Wu GQ: Preparation and characterization of a polyclonal
antibody against human Fibrocystin-L. Xi Bao Yu Fen Zi Mian Yi Xue
Za Zhi. 27:78–81. 2011.(In Chinese). PubMed/NCBI
|
|
20
|
Hogan MC, Griffin MD, Rossetti S, Torres
VE, Ward CJ and Harris PC: PKHDL1, a homolog of the autosomal
recessive polycystic kidney disease gene, encodes a receptor with
inducible T lymphocyte expression. Hum Mol Genet. 12:685–698. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Erdman VV, Karimov DD, Nasibullin TR,
Timasheva IR, Tuktarova IA and Mustafina OE: Role of PLAT, PKHD1L1,
STK38L and TEAD1 genes Alu-polymorphism for longevity. Adv
Gerontol. 29:709–716. 2016.(In Russian). PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Edge SB and Compton CC: The American Joint
Committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mustafa M, Kuwert T, Weber K, Knesewitsch
P, Negele T, Haug A, Linke R, Bartenstein P and Schmidt D: Regional
lymph node involvement in T1 papillary thyroid carcinoma: A
bicentric prospective SPECT/CT study. Eur J Nucl Med Mol Imaging.
37:1462–1466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schneider DF and Chen H: New developments
in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin.
63:374–394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cho SY, Lee TH, Ku YH, Kim HI, Lee GH and
Kim MJ: Central lymph node metastasis in papillary thyroid
microcarcinoma can be stratified according to the number, the size
of metastatic foci, and the presence of desmoplasia. Surgery.
157:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ito Y, Tomoda C, Uruno T, Takamura Y, Miya
A, Kobayashi K, Matsuzuka F, Kuma K and Miyauchi A:
Ultrasonographically and anatomopathologically detectable node
metastases in the lateral compartment as indicators of worse
relapse-free survival in patients with papillary thyroid carcinoma.
World J Surg. 29:917–920. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee YM, Sung TY, Kim WB, Chung KW, Yoon JH
and Hong SJ: Risk factors for recurrence in patients with papillary
thyroid carcinoma undergoing modified radical neck dissection. Br J
Surg. 103:1020–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sancho JJ, Lennard TW, Paunovic I,
Triponez F and Sitges-Serra A: Prophylactic central neck disection
in papillary thyroid cancer: A consensus report of the European
society of endocrine surgeons (ESES). Langenbecks Arch Surg.
399:155–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Comuzzie AG, Cole SA, Laston SL, Voruganti
VS, Haack K, Gibbs RA and Butte NF: Novel genetic loci identified
for the pathophysiology of childhood obesity in the Hispanic
population. PLoS One. 7:e519542012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang QX, Chen ED, Cai YF, Li Q, Jin YX,
Jin WX, Wang YH, Zheng ZC, Xue L, Wang OC and Zhang XH: A panel of
four genes accurately differentiates benign from malignant thyroid
nodules. J Exp Clin Cancer Res. 35:1692016. View Article : Google Scholar : PubMed/NCBI
|
